IL108648A0 - Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing them - Google Patents
Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL108648A0 IL108648A0 IL10864894A IL10864894A IL108648A0 IL 108648 A0 IL108648 A0 IL 108648A0 IL 10864894 A IL10864894 A IL 10864894A IL 10864894 A IL10864894 A IL 10864894A IL 108648 A0 IL108648 A0 IL 108648A0
- Authority
- IL
- Israel
- Prior art keywords
- condensed
- preparation
- pharmaceutical compositions
- compositions containing
- membered heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4304650A DE4304650A1 (de) | 1993-02-16 | 1993-02-16 | Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL108648A0 true IL108648A0 (en) | 1994-05-30 |
Family
ID=6480585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10864894A IL108648A0 (en) | 1993-02-16 | 1994-02-15 | Condensed five-membered heterocyclic compounds, their preparation and pharmaceutical compositions containing them |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0611660A3 (enExample) |
| JP (1) | JPH072839A (enExample) |
| AU (1) | AU5513094A (enExample) |
| CA (1) | CA2115737A1 (enExample) |
| DE (1) | DE4304650A1 (enExample) |
| FI (1) | FI940697A7 (enExample) |
| IL (1) | IL108648A0 (enExample) |
| NO (1) | NO940524D0 (enExample) |
| NZ (1) | NZ250879A (enExample) |
| ZA (1) | ZA941021B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751647B1 (fr) * | 1996-07-25 | 1998-09-11 | Synthelabo | Derives de benzimidazole, leurs preparations et leurs applications en therapeutique |
| HRP20000209A2 (en) | 1997-10-20 | 2001-04-30 | Hoffmann La Roche | Bicyclic kinase inhibitors |
| MXPA03007621A (es) | 2001-02-23 | 2003-12-04 | Merck & Co Inc | Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos. |
| EA200400595A1 (ru) | 2001-11-09 | 2004-10-28 | Бёрингер Ингельхайм Фармасьютиклз, Инк. | Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы |
| JP2005536533A (ja) | 2002-08-08 | 2005-12-02 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 置換ベンゾイミダゾール化合物 |
| DK1587821T6 (da) | 2002-12-19 | 2025-05-26 | Scripps Research Inst | Sammensætninger og fremgangsmåder til stabilisering af trans-thyretin og inhibering af transthyretin-fejlfoldning |
| EP1479676A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Benzimidazole-derivatives as factor xa inhibitors |
| US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
| BRPI0413234A (pt) | 2003-08-01 | 2006-10-03 | Genelabs Tech Inc | derivados de imidazola bicìclica contra flaviviridae |
| WO2005112913A1 (en) | 2004-05-20 | 2005-12-01 | The Scripps Research Institute | Transthyretin stabilization |
| JP5603248B2 (ja) * | 2007-12-21 | 2014-10-08 | エンダセア， インコーポレイテッド | Ａ１アデノシン受容体アンタゴニスト |
| WO2013038351A1 (en) | 2011-09-16 | 2013-03-21 | Pfizer Inc. | Solid forms of a transthyretin dissociation inhibitor |
| EP2956450B1 (en) | 2013-02-14 | 2018-07-25 | Technische Universität München | Hydroxyindalpine derivatives and their medical use |
| WO2014151630A2 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
| MX370372B (es) | 2013-03-15 | 2019-12-11 | Hydra Biosciences Inc | Xantinas sustituidas y metodos de uso de las mismas. |
| US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| JP6392352B2 (ja) | 2013-12-19 | 2018-09-19 | ノバルティス アーゲー | リーシュマニア症などの寄生虫病を処置するための原生動物のプロテアソーム阻害剤としての［１，２，４］トリアゾロ［１，５−ａ］ピリミジン誘導体 |
| US10112901B2 (en) | 2014-07-03 | 2018-10-30 | Shanghai Institute Of Pharmaceutical Industry | Method for preparing dabigatran etexilate intermediate, and intermediate compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2208367B (en) | 1987-07-09 | 1991-07-03 | Alcatel Business Systems | Franking machine |
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4214245A1 (de) * | 1992-04-30 | 1993-11-04 | Thomae Gmbh Dr K | Tritiummarkierte fibrinogen-rezeptor-antagonisten, deren verwendung und verfahren zu ihrer herstellung |
| DE59303178D1 (de) * | 1992-04-28 | 1996-08-14 | Thomae Gmbh Dr K | Tritiumarkierte Fibrinogen-Rezeptor-Antagonisten, deren Verwendung und Verfahren zur ihrer Herstellung |
-
1993
- 1993-02-16 DE DE4304650A patent/DE4304650A1/de not_active Withdrawn
-
1994
- 1994-02-14 EP EP9494102222A patent/EP0611660A3/de not_active Withdrawn
- 1994-02-14 JP JP6017568A patent/JPH072839A/ja active Pending
- 1994-02-15 AU AU55130/94A patent/AU5513094A/en not_active Abandoned
- 1994-02-15 IL IL10864894A patent/IL108648A0/xx unknown
- 1994-02-15 NZ NZ250879A patent/NZ250879A/xx unknown
- 1994-02-15 FI FI940697A patent/FI940697A7/fi not_active Application Discontinuation
- 1994-02-15 NO NO940524A patent/NO940524D0/no unknown
- 1994-02-15 CA CA002115737A patent/CA2115737A1/en not_active Abandoned
- 1994-02-15 ZA ZA941021A patent/ZA941021B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI940697A7 (fi) | 1994-08-17 |
| CA2115737A1 (en) | 1994-08-17 |
| EP0611660A3 (de) | 1994-09-14 |
| AU5513094A (en) | 1994-08-18 |
| ZA941021B (en) | 1995-08-15 |
| NZ250879A (en) | 1995-09-26 |
| FI940697A0 (fi) | 1994-02-15 |
| NO940524D0 (no) | 1994-02-15 |
| JPH072839A (ja) | 1995-01-06 |
| DE4304650A1 (de) | 1994-08-18 |
| EP0611660A2 (de) | 1994-08-24 |
| NO940524L (enExample) | 1994-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL102638A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL103053A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL108436A0 (en) | Five-membered heterocycles, their preparation and pharmaceutical compositions containing them | |
| IL98393A0 (en) | Thiophene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL116957A0 (en) | Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them | |
| HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
| IL110743A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL96577A0 (en) | Heterocyclic substituted acylaminothiazoles,their preparation and pharmaceutical compositions containing them | |
| HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
| NZ255505A (en) | Substituted thiazolidinedione derivatives, preparation and pharmaceutical compositions thereof | |
| HUT74464A (en) | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them | |
| IL110793A0 (en) | Benzofuran derivatives, their preparation and pharmaceutical compositions containing them | |
| IL112193A0 (en) | Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL98873A0 (en) | Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL112443A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
| IL98756A0 (en) | Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation | |
| IL108703A0 (en) | Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them | |
| IL117620A0 (en) | Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ZA941021B (en) | Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds. | |
| IL111011A0 (en) | Bisbenzimidazole compounds, their preparation and pharmaceutical compositions containing them | |
| HUP0201714A3 (en) | Substituted heterocyclic compounds and pharmaceutical compositions containing them | |
| IL108800A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
| HUP9900865A3 (en) | Anti-viral benzimidazole derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| IL106385A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| ZA911804B (en) | 1-azabicyclic compounds,processes and pharmaceutical compositions containing them |